XTalks

DECEMBER 20, 2022

“This is another important milestone for Fresenius Kabi in fulfilling our strategic priority of introducing biosimilars for patients worldwide,” said Dr. Michael Schönhofen, Fresenius Kabi’s Chief Operating Officer and Member of the Fresenius Kabi Management Board, in the company’s press release. “In

FDA Approval 98

FDA Approval Allergies Manufacturing Clinical Trials 98

XTalks

MARCH 12, 2024

Wegovy’s efficacy and safety for its heart indication were assessed in Novo’s Phase III SELECT cardiovascular outcomes trial that included 17,604 participants who received either Wegovy or placebo, along with standard-of-care treatment like management of blood pressure and cholesterol and counseling about diet and physical activity.

Drugs 105

Drugs Production Trials Clinical Trials 105

pharmaphorum

AUGUST 18, 2020

The Accenture survey of 720 general practitioners, oncologists, cardiologists and immunologists globally found that this is in turn helping HCPs better serve patients. Indeed, 43% of HCPs said they are currently restricting who can enter the office for professional reasons (i.e. The impact on launch. no pharmaceutical reps).

Pharma Companies 129

Pharma Companies Sales Life Science Marketing 129

XTalks

NOVEMBER 11, 2022

Investors include Rodger May, owner and chief growth officer of Peter Pan Seafood, and Per Heggelund, former owner and operator of a freshwater land-based coho salmon farm in Washington state. Land-based aquaculture will play a major role in the future of American seafood,” said Rodger May, in the same press release.

Marketing 52

Marketing Production Sales Development 52

XTalks

MAY 11, 2022

The company is addressing some of the most pressing concerns for consumers who pay the closest attention to their food products, with more than half of consumers more likely to buy products with sustainability label claims. Not to mention, about 6.1 The global market for ethical food is projected to grow to $727.86

Production 98

Production Containment Branding Packaging 98

The Pharma Data

JULY 12, 2021

The Phase 3 portion of the global MOVe-OUT trial studying molnupiravir in non-hospitalized adult patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes is underway. This press release features multimedia. “It About Molnupiravir. About Ridgeback Biotherapeutics.

Clinical Trials 52

Clinical Trials Clinical Trials Bioavailability Trials 52

pharmaphorum

NOVEMBER 25, 2022

Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially Italian affair, based out of Chiesi’s San Leonardo production site. The situation was reversed only 25 years ago.

Antibody 98

Antibody Production Manufacturing Development 98

XTalks

MARCH 6, 2023

On February 27 th , 2023, Dr. Reddy’s Laboratories announced in a press release that the company had entered an agreement with Mayne Pharma Group Ltd. is a global pharmaceutical company based in Hyderabad, India. to acquire Mayne Pharma’s US generic prescription products portfolio. Dr. Reddy’s Laboratories Ltd.

Production 98

Production Branding Dermatology Hormones 98

XTalks

FEBRUARY 3, 2023

. “The FDA approval of Orserdu marks the first ever therapy for ER+, HER2- advanced or metastatic breast cancer patients with ESR1 mutations and we are very proud to offer a targeted therapy addressing this huge unmet need,” said Elcin Barker Ergun, chief executive officer of the Menarini Group, in a new press release.

Clinical Trials 97

Clinical Trials Clinical Trials FDA Approval Trials 97

Pfizer

JANUARY 17, 2023

About Pfizer: Breakthroughs That Change Patients’ Lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Abzena. The information contained in this press release is as of January 17, 2023. Disclosure Notice.

Manufacturing 85

Manufacturing Containment Development Medicine 85

XTalks

DECEMBER 20, 2023

The global market for pain management is substantial, driven by an aging population, increased prevalence of chronic diseases and a rising number of surgical procedures. Xtalks interviewed Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences, to learn about the current innovation priorities at Ensysce. billion in 2023 to $89.96

Production 111

Production Drugs Development Medicine 111

XTalks

JUNE 20, 2023

Uber), globally recognized for its ride-hailing, food delivery, package delivery and freight transport services, has announced an extension of its healthcare division, Uber Health. Uber Technologies, Inc. This personalization equips patients with the necessary tools for healthier lifestyles, enhancing their overall healthcare experience.

Medicine 91

Medicine Packaging Packaging Production 91

The Pharma Data

JANUARY 4, 2021

has been appointed Chief Financial Officer. This press release features multimedia. as Chief Financial Officer. We are delighted to welcome George to the senior leadership team as we are poised to build on the momentum of the past year,” said Daphne Zohar, Founder and Chief Executive Officer of PureTech.

Development 52

Development Marketing Production Medicine 52

XTalks

OCTOBER 17, 2023

“Velsipity provides adults living with moderately to severely active UC the opportunity to achieve steroid-free remission with an oral, once-daily pill that has a favorable benefit-risk profile,” said Angela Hwang, Chief Commercial Officer and President of Global Biopharmaceuticals Business at Pfizer, in a press release from the company.

FDA Approval 59

FDA Approval Drugs Trials Clinical Trials 59

pharmaphorum

OCTOBER 13, 2022

About the interviewees. Lee Taurman – Executive Vice President, Global Head of Full-Service Commercial, Syneos Health. Commercial Innovation leverages our broad commercial and clinical capabilities to develop integrated solutions that address our clients most pressing needs. About Syneos Health.

Vaccination 52

Vaccination Vaccine Life Science Development 52

The Pharma Data

JULY 29, 2021

Takeda will retain commercialization rights in Japan and HilleVax will integrate certain Japan development activities into its global development. President of the Global Vaccine Business Unit, Takeda. Vaccines prevent 2 to 3 million deaths each year and have transformed global public health. About Frazier Healthcare Partners.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

XTalks

MAY 25, 2022

Fibromyalgia affects approximately 4 million adults in the US, which is about 2 percent of the US adult population. Gozani, MD, PhD, Chief Executive Officer of NeuroMetrix in the company’s press release. XTALKS WEBINAR: Using the Pain Catastrophizing Scale in Clinical Research and Practice.

FDA Approval 105

FDA Approval Clinical Trials Clinical Trials Drugs 105

pharmaphorum

JULY 5, 2022

While Whitty deftly deferred a question around the impact of Brexit on funding to his government colleagues, he does see supporting the workforce as the most pressing priority, along with the need to manage press around the NHS as it innovates. About the author. Accelerating access for patients. A golden age? Absolutely.

Life Science 98

Life Science Biobanking Medicine Marketing 98

The Pharma Data

JANUARY 14, 2021

Principal investigator for the Phase II trial will be Dr. Ben Sessa, Chief Medical Officer of Awakn, who previously led the world’s only MDMA and AUD study. I am pleased that we at Awakn are spear-heading the global initiative to develop new efficacious strategies for tackling this condition. ” About Awakn Life Sciences.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

XTalks

NOVEMBER 6, 2023

XTALKS WEBINAR: Warehouse Automation Within the Pharmaceutical Industry: Logistics from Dock to Dock Live and On-Demand: Tuesday, December 5, 2023 , at 11am PST (2pm EST) Register for this free webinar to learn about the implementation of warehousing and logistics within the pharmaceutical industry. billion in 2022 and is expected to hit $5.95

FDA Approval 64

FDA Approval Marketing Drugs Sales 64

The Pharma Data

NOVEMBER 29, 2020

This press release features multimedia. Dr. Samuel Cohen, Chief Executive Officer of Wren, commented : “We are delighted to have formed this collaboration with Eisai, a company with a distinguished track record and company-wide commitment to providing innovative treatments for patients suffering from neurodegenerative diseases.

Research 52

Research Drugs Protein Development 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccination 52

Vaccination Vaccine Trials Protein 52

The Pharma Data

NOVEMBER 17, 2021

We’re proud to bring Trillium’s leading scientific gift and channel into Pfizer,” said Chris Boshoff, MD, PhD, Chief Development Officer, Oncology, Pfizer Global Product Development. For fresh background on the accession, please read the advertisement press release then. About Pfizer Oncology.

Protein 52

Protein Development Production Sales 52

XTalks

AUGUST 11, 2020

It’s hard enough to get older adults to get routine vaccines but during a global pandemic, it’s nearly impossible. Data from IQVIA seems to support this claim, with physicians’ offices and other healthcare centers ordering 62 percent fewer adult vaccines between April and May of 2020, compared to the same time period in 2019.

Vaccination 88

Vaccination Vaccine Doctors Doctor 88

pharmaphorum

MARCH 17, 2022

The reason why this has become such a pressing issue is due to the rapid growth of digital healthcare solutions, which now include mobile healthcare applications, digital therapeutics, health information technology, telehealth and telemedicine, personalised medicine, and wearable devices. Whole system approach.

Development 145

Development Marketing Research Medicine 145

The Pharma Data

OCTOBER 25, 2020

“We appreciate the confidence of the Ministry of Health of Qatar in our mRNA vaccine platform and the collaboration we have had to date,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “We For more information about the COVE study, click here. About Moderna. Department of Health and Human Services (HHS).

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Development 52

XTalks

JUNE 20, 2023

While many DLBCL patients respond to conventional treatments, about 40 percent will relapse or have refractory disease and subsequent treatments for them have poor outcomes. Previous treatments included about one-third who had received CAR T-cell therapy.

Antibody 98

Antibody Trials Drugs FDA Approval 98

The Pharma Data

MAY 4, 2021

Ricks , Lilly Chairman and Chief Executive Officer. Improving access to quality health care for 30 million people globally living in limited resource settings annually by 2030 through the Lilly 30×30 initiative. ” More information about Lilly ‘s ESG strategy and progress is available at esg.lilly.com.

Medicine 52

Medicine Insulin Containment Production 52

The Pharma Data

DECEMBER 16, 2020

The global reach of the pandemic requires that all regions of the world have an adequate supply of vaccine available to protect their entire citizenry,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “We About NVX-CoV2373. About Matrix-M. About Novavax. and Australia. Novavax, Inc.?(Nasdaq:

Protein 52

Protein Vaccination Vaccine Immune Response 52

The Pharma Data

DECEMBER 14, 2020

and exemplifies our global growth strategy,” said Ron Andrews, Chief Executive Officer and President of Oncocyte. “We Yusheng Han, Founder and Chief Executive Officer of Burning Rock added, “We are excited to be entering into this agreement with Oncocyte. About Burning Rock. About Oncocyte Corporation.

Licensing 52

Licensing Licensing Marketing Gene Expression 52

The Pharma Data

JANUARY 31, 2021

Since 2010, Dr Dohrmann has been serving Evotec as Chief Scientific Officer and Member of the Management Board. ” To learn more about the German Council of Science and Humanities, please follow this link (only available in German). DeveloGen was acquired by Evotec in 2010. 0)40.56081-255, gabriele.hansen@evotec.com.

Containment 52

Containment Development Production Drugs 52

The Pharma Data

MAY 31, 2022

“We thank Takeda for their support and partnership in bringing our COVID-19 vaccine to Japan over the last two years, and for helping to play a key role in addressing the pandemic across the country,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “We President, Global Vaccine Business Unit at Takeda. About Moderna.

Vaccination 52

Vaccination Vaccine Marketing RNA 52

The Pharma Data

APRIL 26, 2021

This is a joint press release by Sanofi Foreign Participations B.V. Terms not defined in this press release will have the meaning as set forth in the Offer Memorandum. . Announcements Any announcement contemplated by the Offer Memorandum will be issued by press release. Settlement Agent ING Bank N.V.

Containment 40

Containment Regulation Marketing Production 40

The Pharma Data

DECEMBER 16, 2020

The agreement leverages Otsuka’s well-recognized expertise in rare kidney diseases to underscore Aurinia’s commitment to expanding global access to voclosporin for the treatment of LN. About Lupus Nephritis LN is an inflammation of the kidney caused by SLE and represents a serious progression of SLE.

Licensing 52

Licensing Licensing Development Sales 52

The Pharma Data

DECEMBER 21, 2020

22, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Christian Hogg, Chief Executive Officer, will present at the 39 th Annual JP Morgan Healthcare Conference taking place virtually on Monday January 11, 2021 at 8 a.m. About Chi-Med. EST (1 p.m. GMT / 9 p.m. CONTACTS.

Containment 40

Containment Marketing Development Drugs 40

The Pharma Data

MARCH 20, 2023

The findings of this academic paper about the societal value of lecanemab in the U.S. While a broader range of values was considered, the severity-adjusted WTP threshold of $200,000 per QALY gained accurately reflects the societal value of lecanemab,” said Ivan Cheung , Senior Vice President, and Global Alzheimer’s Disease Officer, Eisai Co.,

Antibody 40

Antibody Branding Production Development 40

The Pharma Data

JUNE 7, 2022

Sanofi today launches Action 2022, its global employee share ownership plan, open to 86 000 employees in 59 countries. Paul Hudson Chief Executive Officer of Sanofi “ I strongly believe along with the Board of Directors that a high employee shar eholding contributes to develop a common spirit and unite our employees worldwide.

Regulation 40

Regulation Development Vaccination Vaccine 40